Skip to main content

Home/ Cancer/ Group items tagged anti-cancer June

Rss Feed Group items tagged

Matti Narkia

Green tea 'slows prostate cancer' - BBC NEWS | Health - 0 views

  •  
    A chemical found in green tea appears to slow the progression of prostate cancer, a study has suggested.
    Green tea has been linked to a positive effect on a wide range of conditions, including heart disease, cancer and Alzheimer's disease.
Matti Narkia

Common diabetes drug may 'revolutionize' cancer therapies - 1 views

  •  
    Researchers at McGill University and the University of Pennsylvania have discovered that a widely used anti-diabetic drug can boost the immune system and increase the potency of vaccines and cancer treatments. Their findings will be published June 3 in the journal Nature.

    The discovery was made by Dr. Russell Jones, an assistant professor at McGill's Goodman Cancer Centre and the Department of Physiology, Faculty of Medicine, Yongwon Choi, PhD, professor of pathology and laboratory medicine, and postdoctoral fellow Erika Pearce, PhD, of the University of Pennsylvania. They discovered that the widely prescribed diabetes treatment metformin increases the efficiency of the immune system's T-cells, which in turn makes cancer and virus-fighting vaccines more effective.
Matti Narkia

Coriolus versicolor and cancer (June 2003) - 0 views

  •  
    Attached please find the final draft of Dr. Kenyon's non-controlled observational study on the use of Coriolus versicolor (non-extracted) in 30 solid tumour cancer patients. The final report will be published in the February edition of Mycology News 7.
    The patients were Stage III and Stage IV patients in which chemotherapy and radiotherapy were not considered successful. Below please find a synopsis of patient type.
Matti Narkia

Phase I trial of Seneca Valley Virus (NTX-010), a newly discovered systemically deliver... - 0 views

  •  
    Phase I trial of Seneca Valley Virus (NTX-010), a newly discovered systemically deliverable oncolytic picornavirus, in patients with solid tumors with neuroendocrine features.
    C. M. Rudin, D. Lansey, K. D. Burroughs, L. M. Hales, J. R. Neefe, P. S. Reddy and P. L. Hallenbeck
    Johns Hopkins Univ, Baltimore, MD; Neotropix, Inc., Malvern, PA.
    Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings (Post-Meeting Edition).
    Vol 25, No 18S (June 20 Supplement), 2007: 18014
    © 2007 American Society of Clinical Oncology.

    Conclusions: NTX-010 is a novel first-in-class anticancer virus with selective tropism for tumors with neuroendocrine features. This is the first anticancer virus given intravenously with documented selective intratumoral infection and replication. Administration was well tolerated. Safety data and viral kinetics will be presented.

Matti Narkia

Anti-proliferative and antioxidant properties of rosemary Rosmarinus officinalis - 0 views

  •  
    Anti-proliferative and antioxidant properties of rosemary Rosmarinus officinalis.
    Cheung S, Tai J.
    Oncol Rep. 2007 Jun;17(6):1525-31.
    PMID: 17487414
1 - 5 of 5
Showing 20 items per page